February 1, 2024 Comments Off on New patent for Abbvie drug RESTASIS Posted in: Patent Added Annual Drug Patent Expirations for RESTASIS Restasis is a drug marketed by Abbvie and is included in one NDA. It is available from four suppliers. There are ten patents protecting…
The post New patent for Abbvie drug RESTASIS appeared first on DrugPate…
February 1, 2024 Comments Off on New patent for Janssen Prods drug EDURANT Posted in: Patent Added Annual Drug Patent Expirations for EDURANT Edurant is a drug marketed by Janssen Prods and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent for Janssen Prods drug EDURANT appeared first on DrugPate…
